Borealis film stays clear even post-sterilisation
High-transparency is retained during and after sterilisation, which Borealis believes will make its film, called Bormed RE806CF, highly desirable to manufacturers of pharmaceutical, medical device and diagnostic packaging.
Borealis claims the film’s high-transparency, coupled with its very high gloss, low haze, 143ºC melting point and good sealability, put it at the forefront of existing copolymer offerings.
Nina Ackermans, application marketing manager, Borealis Film and Fibre Business Unit, said: “Bormed RE806CF is an excellent example of Borealis’ commitment to investing in new technologies.
“We understand the high value that our customers in the medical film industry place on product consistency, reliability of supply and easy processing, in addition to responding to the aesthetic and performance criteria required by the demanding healthcare market. Bormed RE806CF has been tailored to help cast film converters meet these challenges.”
The film is based upon Borealis’ Borstar-Sirius catalyst technology, which is the company’s proprietary manufacturing technique for tailoring the molecular structure of polyolefins to meet a client’s needs.
Borealis claims use of this technology allows it to produce polymers with high environmental stress-cracking resistance, low shrinkage and a tailored balance between stiffness and impact.
The film will be manufactured at Borealis’ new PP facility in Burghausen, Germany, which operates under conditions designed to ensure consistent, high quality and compliance with international standards.
